CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy, and Tomocube, a leader in holotomography (HT) technology, today announced a ...
A novel optical microscope utilizing diffraction tomography to generate 3D holographic images of unlabeled live cells is now available from Tomocube. Called HT-1, the new microscope delivers ...
Tomocube (Co-CEOs Yonggeun Park and Kihyun Hong), a specialized company in three-dimensional label-free cell imaging, announced on the 25th that it has finalized its public offering price at 16,000 ...
TomoCube, a South Korea-based developer of optical and microscopy platforms for bioimaging, expects its latest holotomography system to prove the value of the technique in a number of applications.
Tomocube is experiencing a sharp decline compared to its IPO price on the first day of listing on the KOSDAQ market. As of 10:29 AM on the 7th, Tomocube is trading at 11,700 KRW, down 26.88% from its ...
Tomocube, a global leader in 3D label-free imaging and analysis, proudly introduces the HT-X1™ Plus, a state-of-the-art bioimaging platform designed to meet the evolving needs of biomedical ...
The Korea Herald is publishing a series of articles highlighting South Korea’s promising start-ups in the emerging sectors of digital health care and next-generation medical devices. This is the third ...
-- First commercially available spinning-disk confocal holotomographic instrument, enabling advanced 3D imaging with fluorescence-based detection -- New system showcased at SPAOM24 (20th-22nd November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results